bioRxiv Science⌕ Search

Biology subjects

Sevim, S.

Publications and source records attributed to Sevim, S..

2 recordsLinked to original sources

MiroSCOPE: An AI-driven digital pathology platform for annotating functional tissue units

Cancer tissue analysis in digital pathology is typically conducted across different spatial scales, ranging from high-resolution cell-level modeling to lower-resolution tile-based assessments. However, these perspectives often overlook the structural organization of functional tissue units (FTUs), the small, repeating structures which are crucial to tissue function and key factors during pathological assessment. The incorporation of FTU information is hindered by the need for detailed manual annotations, which are costly and time-consuming to obtain. While artificial intelligence (AI)-based solutions hold great promise to accelerate this process, there is currently no comprehensive workflow for building the large, annotated cohorts required. To remove these roadblocks and advance the development of more interpretable approaches, we developed MiroSCOPE, an end-to-end AI-assisted platform for annotating FTUs at scale, built on QuPath. MiroSCOPE integrates a fine-tunable multiclass segmentation model and curation-specific usability features to enable a human-in-the-loop system that accelerates AI annotation by a pathologist. The system is used to efficiently annotate over 71,900 FTUs on 184 prostate cancer hematoxylin and eosin (H&E)-stained tissue samples and demonstrates ready translation to breast cancer. Furthermore, we publicly release a dataset named Miro-120, consisting of 120 prostate cancer H&E with 30,568 annotations, which can be used by the community as a high-quality resource for FTU-level machine learning aims. In summary, MiroSCOPE provides an adaptable AI-driven platform for annotating functional tissue units, facilitating the use of structural information in digital pathology analyses.

bioinformatics↗

Magnetoelectric Microrobots for Spinal Cord Injury Regeneration

Regenerative medicine continually seeks effective methods to address spinal cord injuries (SCI), which are known for their limited regenerative potential. Despite advances in neural progenitor cell (NPC) transplants for spinal cord injuries, challenges related to graft survival, reliable in vivo differentiation, and neural integration significantly hinder real functional recovery and limit clinical outcomes. This study introduces NPCbots, biohybrid microrobots engineered by integrating human-induced pluripotent stem cell-derived NPCs with magnetoelectric nanoparticles composed of cobalt ferrite-barium titanate. These enable magnetic navigation and neuronal stimulation, enhancing targeted therapeutic interventions. Our lab-on-a-chip system allows for the mass production of NPCbots, ensuring their differentiation and biocompatibility. Remarkably, in a zebrafish model of SCI, NPCbots stimulated by an alternating magnetic field demonstrated rapid in vivo differentiation and integration into damaged neural pathways, significantly enhancing neural regeneration. Within three days, injured zebrafish treated with NPCbots exhibited almost normal swimming behavior and significantly improved exploratory behavior, showcasing the potential of NPCbots to swiftly repair neural structures and restore the central nervous systems functionality in spinal cord injury models through non-invasive means. Additionally, precise in vitro and in vivo manipulation of NPCbots indicates their broader application in various neurodegenerative disorders, offering a promising route for effective spinal cord and neurological recovery.

neuroscience↗